In 2025, the Centers for Disease Control and Prevention (CDC) faces unprecedented scrutiny. Once regarded as the cornerstone of American public health, the agency now struggles with declining public trust, internal workforce challenges, and increasing political interference. Simultaneously, ivermectin has re-emerged as a divisive topic in U.S. healthcare, sparking debates...